These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1489229)

  • 1. Thrombolysis with low dose tissue plasminogen activator.
    Doyle E; Britto J; Freeman J; Munro F; Morton NS
    Arch Dis Child; 1992 Dec; 67(12):1483-4. PubMed ID: 1489229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caval thrombolysis in neonates using low doses of recombinant human tissue-type plasminogen activator.
    Anderson BJ; Keeley SR; Johnson ND
    Anaesth Intensive Care; 1991 Feb; 19(1):22-7. PubMed ID: 1901463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy.
    Dillon PW; Fox PS; Berg CJ; Cardella JF; Krummel TM
    J Pediatr Surg; 1993 Oct; 28(10):1264-8; discussion 1268-9. PubMed ID: 8263684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
    Schranz D; Haugwitz D; Zimmer B; Schumacher R
    Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
    Özkan M; Çakal B; Karakoyun S; Gürsoy OM; Çevik C; Kalçık M; Oğuz AE; Gündüz S; Astarcioglu MA; Aykan AÇ; Bayram Z; Biteker M; Kaynak E; Kahveci G; Duran NE; Yıldız M
    Circulation; 2013 Jul; 128(5):532-40. PubMed ID: 23812180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen-enriched pulse-spray thrombolysis with tPA: further developments.
    Bookstein JJ; Bookstein FL
    J Vasc Interv Radiol; 2000; 11(10):1353-62. PubMed ID: 11099249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy with tissue plasminogen activator for superior vena cava thrombosis in an infant with sepsis.
    Tan H; Kizilkaya M; Alper F; Becit N; Kürşat H
    Acta Paediatr; 2005 Feb; 94(2):239-41. PubMed ID: 15981762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator.
    Greenberg S; Kosinski R; Daniels J
    Chest; 1991 May; 99(5):1298-301. PubMed ID: 1902161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-Directed Low-Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter.
    Orgeron GM; Pollard JL; Pourmalek P; Sloane PJ
    Pharmacotherapy; 2015 Oct; 35(10):e153-8. PubMed ID: 26497485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Loco-regional thrombolysis in deep venous thrombosis].
    Palombo D; Porta C; Brustia P; Peinetti F; Udini M; Antico A; Maione M; Meloni T; Carbonato P
    Phlebologie; 1993; 46(2):293-302. PubMed ID: 8362012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented experimental pulse-spray thrombolysis with tissue plasminogen activator, enabling dose reduction by one or more orders of magnitude.
    Bookstein JJ; Bookstein FL
    J Vasc Interv Radiol; 2000 Mar; 11(3):299-303. PubMed ID: 10735423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intrathrombic administration of prostaglandin E1 during pulse-spray thrombolysis with tissue-type plasminogen activator in experimental thrombosis.
    Valji K; Bookstein JJ
    Radiology; 1993 Mar; 186(3):873-6. PubMed ID: 8430201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis].
    Pucheu A; Dierhas M; Leduc B; Sillet-Bach I; Lefort S; Assaf W; Pucheu M
    Bull Cancer; 1996 Apr; 83(4):293-9. PubMed ID: 8680080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy in preterm infants: Fifteen-year experience.
    Grizante-Lopes P; Garanito MP; Celeste DM; Krebs VLJ; Carneiro JDA
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28544. PubMed ID: 32710708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial.
    Özkan M; Kalçık M; Gürsoy MO; Öcal L; Griffini S; Karakoyun S; Yesin M; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Aykan AÇ; Cugno M
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children.
    Shea M; Hmiel SP; Beck AM
    Adv Perit Dial; 2001; 17():249-52. PubMed ID: 11510286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local thrombolysis with stent implantation in a patient with vena cava superior syndrome].
    Vik A; Kumar S; Singh K; Hansen JB
    Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2049-50. PubMed ID: 12934129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iatrogenic superior vena cava syndrome. Successful thrombolysis with recombinant tissue plasminogen activator (r-tPA)].
    Sternlo JE; Askelöf N
    Lakartidningen; 1992 Jan; 89(4):214-5. PubMed ID: 1734155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.